首页> 外国专利> A PROCESS FOR THE CHARACTERIZATION OF THE BIOACTIVE COMPONENT PRESENT IN BARK AND SEEDS OF EUGENIA JAMBOLANA (JAMUN) USED IN HERBAL REMEDIES FOR THE TREATMENT OF DIABETIC

A PROCESS FOR THE CHARACTERIZATION OF THE BIOACTIVE COMPONENT PRESENT IN BARK AND SEEDS OF EUGENIA JAMBOLANA (JAMUN) USED IN HERBAL REMEDIES FOR THE TREATMENT OF DIABETIC

机译:一种用于治疗糖尿病的中药材赤IA中树皮和种子中生物活性成分的表征方法

摘要

The present invention relates to a process for the characterization of bioactive components present in Eugenia jambolana (jamun) used in herbal remedies for the treatment of diabetic. Activity present in alcoholic extracts or in low molecular weight (5000 Dalton) fraction of the aqueous extracts of bark and seeds reversibly inhibits activities of maltase and sucrase of both mammalian and microbial origins and thus regulates blood glucose level in diabetics. One of the most direct and beneficial types of therapy for non-insulin dependent diabetics is achieved by control of blood glucose level after meal by delaying glucose absorption. These enzymes are involved in the gastric digestion of starch into glucose and enzymatic hydrolysis sucrose into glucose entering into blood stream. Pancreatic amylase directly participate in starch digestion producing maltose as the major end product while membrane-bound maltase and sucrase at the epithelium of the small intestine catalyze the cleavage of disaccharide maltose into glucose or sucrose into fructose and glucose which enter into blood stream. Many non-protein low molecular weight inhibitors of alpha-amylase, alpha-glucosidase and sucrase are clinically used (Acarbose, valiolamine and "Miglitol" )for the treatment of type-II or insulin-independent diabetes. Eugenia jambolana is used in Indian Ayurvedic Medicine for treating diabetic mellitus and that plant extract lowers blood sugar of alloxan diabetic animals is known. But bioactive component of Eugenia jambolana which might be responsible for lowering blood glucose level is not known. The present invention provides a process for the characterization of inhibitory activities of aqueous extract of Eugenia jambolana seeds or bark on maltase and sucrase activities, which comprise collection of fresh or dried uninfected bark or seeds of Eugenia jambolana washing them with water, blending in blender to paste, separating the aqueous solution by pressure filtration, further filtering the solution by ultrafiltration membrane of 5,000 dalton cut, collecting the filtrate and drying the solution in a lyophilizer, and characterizing the inhibitory activities of the fraction on activities of maltase and sucrase or seeds and bark of Eugenia jambolana on maltase and sucrase activities, which comprise collection of fresh or dried uninfected bark or seeds of Eugenia jambolana; drying them, grinding them to a powder form in a hand mill and extracting each separately with ethyl alcohol for 24 hours, collecting the filtrates, removing alcohol by evaporation of the solvent 50°C and characterizing the inhibitory activities of dried powder on maltase and sucrase. lowering of blood sugar level lowering of blood sugar level..From l00gm of dry bark,4 gms of slid dry material was obtained. From 100 gm of dry seeds 3.2 gm of dry material was obtained. Ethanolic From 100 gm of dry bark 2gm of dry solid material was obtained. From 100 gm of dry seeds 1.4 gm of solid dry material was obtained. Assay of inhibitory activity of the extracts on different glycosidases (Maltase and Sucrase) were performed and IC 50 values and Ki were determined.
机译:本发明涉及表征存在于用于治疗糖尿病的草药中的Eugenia jambolana(jamun)中的生物活性成分的方法。酒精提取物或树皮和种子的水提取物的低分子量(5000道尔顿)馏分中存在的活性可逆地抑制哺乳动物和微生物来源的麦芽糖酶和蔗糖酶的活性,从而调节糖尿病患者的血糖水平。对于非胰岛素依赖型糖尿病患者,一种最直接,最有益的治疗方法是通过延缓餐后血糖的吸收来控制餐后血糖水平。这些酶参与淀粉在胃中的消化,转化为葡萄糖,酶促水解蔗糖转化为葡萄糖,进入血液。胰淀粉酶直接参与淀粉消化,以麦芽糖为主要最终产物,而小肠上皮的膜结合麦芽糖酶和蔗糖酶则催化将二糖麦芽糖裂解成葡萄糖或将蔗糖裂解成果糖和葡萄糖,然后进入血流。临床上许多α-淀粉酶,α-葡萄糖苷酶和蔗糖酶的非蛋白质低分子量抑制剂被用于治疗II型或非胰岛素依赖型糖尿病(阿卡波糖,缬氨酰胺和“ Miglitol”)。 Eugenia jambolana在印度阿育吠陀医学中用于治疗糖尿病,并且已知植物提取物可降低四氧嘧啶糖尿病动物的血糖。但是,可能导致降低血糖水平的Eugenia jambolana的生物活性成分尚不清楚。本发明提供了表征紫丁香种子或树皮的水提取物对麦芽糖酶和蔗糖酶活性的抑制活性的方法,该方法包括收集新鲜的或干燥的未感染的紫丁香树皮或种子,用水洗涤,在搅拌机中混合,制成糊状,通过压力过滤分离水溶液,进一步用5,000道尔顿切口的超滤膜过滤溶液,收集滤液并在冻干机中干燥溶液,并表征级分对麦芽糖酶和蔗糖酶或种子活性的抑制活性。麦芽糖酵母树皮的麦芽糖酶和蔗糖酶活性,包括收集新鲜或干燥的未感染的桑树花树皮或种子;将其干燥,在手磨机中将其研磨成粉末形式,并分别用乙醇萃取24小时,收集滤液,通过在50°C下蒸发溶剂除去醇,并表征干燥粉末对麦芽糖酶和蔗糖酶的抑制活性。降低血糖水平降低血糖水平。从100克干树皮中获得4克滑动的干物质。从100克干种子中获得3.2克干物质。乙醛从100克干树皮中获得2克干固体物质。从100克干种子中获得1.4克固体干物质。进行提取物对不同糖苷酶(麦芽糖酶和蔗糖酶)的抑制活性测定,并测定IC 50值和Ki。

著录项

  • 公开/公告号IN2007KO00619A

    专利类型

  • 公开/公告日2008-11-07

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN619/KOL/2007

  • 发明设计人 SENGUPTA SUBHABRATA;MUKHERJEE ABHISHEK;

    申请日2007-04-20

  • 分类号A61K31/195;

  • 国家 IN

  • 入库时间 2022-08-21 20:07:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号